Liver Embolization ProcedureDescription, Latest Information and Doctors
Liver Embolization Overview
Learn About Liver Embolization
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Etay Ziv is an Interventional Radiologist practicing medicine in New York, New York. He has been practicing medicine for over 18 years. Dr. Ziv is rated as an Elite provider by MediFind in Liver Embolization. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Small Cell Lung Cancer (SCLC), Liver Embolization, and Bone Marrow Aspiration.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Constantinos Sofocleous is a Radiologist practicing medicine in New York, New York. Dr. Sofocleous is rated as an Elite provider by MediFind in Liver Embolization. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Gastroesophageal Junction Cancer, Pleural Effusion, Liver Embolization, and Cardiac Ablation. Dr. Sofocleous is currently accepting new patients.
Riad Salem is an Interventional Radiologist practicing medicine in Chicago, Illinois. Dr. Salem is rated as an Elite provider by MediFind in Liver Embolization. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Mesenteric Venous Thrombosis, Hypersplenism, Prostatic Artery Embolization, and Liver Embolization. Dr. Salem is board certified in American Board Of Radiology - Interventional Radiology And Diagnostic Radiology (Certified) and American Board Of Radiology. Dr. Salem is currently accepting new patients.
Summary: This phase II trial tests how well cemiplimab and transarterial radioembolization (TARE) with yttrium-90 (Y90) SIR-Spheres, registered trademark, works in treating breast cancer that has spread from where it first started (primary site) to the liver (metastatic). Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the tumor, and may interfere with...
Summary: This phase 1 study is to determine the optimal dose and tolerability of a hypoxia-activating agent, tirapazamine, when it is combined with embolization in liver cancer. Liver cancer patients who are Child-Pugh score A, suitable for embolization with tumor no more than 4 nodules are eligible. Tirapazamine will be given by intra-arterial injection before embolization. Treatment effect is evaluated b...